CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997?2003
about
Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom.Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDS.Accounting for data errors discovered from an audit in multiple linear regressionHIV testing in non-traditional settings--the HINTS study: a multi-centre observational study of feasibility and acceptabilityOlder HIV-infected individuals present late and have a higher mortality: Brighton, UK cohort study.Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.Assessing the predictive value of HIV indicator conditions in general practice: a case-control study using the THIN databaseNon-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UK.Beliefs in Antiretroviral Treatment and Self-Efficacy in HIV Management are Associated with Distinctive HIV Treatment Trajectories.Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort.[Initiation of antiretroviral therapy in HIV-infected patients with severe immunodeficiency in Belo Horizonte, Minas Gerais State, Brazil].HIV testing in Scottish dermatology, a national audit.Gender and mental health aspects of living with HIV disease and its longer-term outcomes for UK heterosexual patients.Up to the test? Routine HIV testing in everyday clinical practice
P2860
Q33506612-1E360BC8-AF31-4BD1-BC6E-CA0656B92B05Q33790033-BBB6D69F-7531-49EB-9E72-96843DA3223CQ33807678-87B96EFE-631A-49DC-93D6-FE9515A8F02FQ34321493-9B69332B-9459-487D-A971-70301BF3B6F0Q34691316-340FDE4A-9B48-4027-A084-A7AAC5305010Q35316315-4A11665C-A6AE-48F4-8187-D15A374F9A63Q35834104-23295738-55C3-41F7-82C6-20AD2386E2B7Q36870581-C40179C4-1005-45A5-9486-D37E18AF9812Q38435854-E0945375-E3B9-4458-A286-F512588F880DQ40403079-8CA7D641-55D5-498E-A016-E27487EABDA2Q42248751-864EA0B3-FF72-4963-B800-C858739F1B8BQ44179108-D4B4C9BB-5CD9-49C1-B545-10D772B2754AQ44567260-0B735B99-C7CE-424F-9821-22C1ED8BF1F9Q48450425-7FB788D4-D08E-4AE0-868B-7DADE66B0F62Q56774763-1D646AF0-D10C-45E3-9579-DE4961016093
P2860
CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997?2003
description
im April 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 April 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2007
@uk
name
CD4 cell count and initiation ...... in seven UK centres, 1997?2003
@en
CD4 cell count and initiation ...... in seven UK centres, 1997?2003
@nl
type
label
CD4 cell count and initiation ...... in seven UK centres, 1997?2003
@en
CD4 cell count and initiation ...... in seven UK centres, 1997?2003
@nl
prefLabel
CD4 cell count and initiation ...... in seven UK centres, 1997?2003
@en
CD4 cell count and initiation ...... in seven UK centres, 1997?2003
@nl
P2093
P2860
P1433
P1476
CD4 cell count and initiation ...... in seven UK centres, 1997-2003
@en
P2093
An Phillips
Ma Johnson
P Easterbrook
UK CHIC Study
P2860
P304
P356
10.1111/J.1468-1293.2007.00443.X
P577
2007-04-01T00:00:00Z